spc1001
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 25, 2022 (NCT06212648)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07064525 | Phase 2 | Dec 5, 2024 | Shin Poong Pharmaceuticals |
| NCT06826872 | Phase 2 | Jun 12, 2024 | Shin Poong Pharmaceuticals |
| NCT06212648 | Phase 2 | Mar 25, 2022 | Shin Poong Pharmaceuticals |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Shin Poong Pharmaceuticals | For profit | 3 | 3 | 1 | 2022 |
1 organizations
Page 1 / 1